Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.

Bedrosian I, Hu CY, Chang GJ.

J Natl Cancer Inst. 2010 Mar 17;102(6):401-9. doi: 10.1093/jnci/djq018. Epub 2010 Feb 25.

2.

Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K.

Ann Surg Oncol. 2014 Oct;21(10):3231-9. doi: 10.1245/s10434-014-3956-3. Epub 2014 Aug 1.

PMID:
25081341
3.

Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.

Kruper L, Kauffmann RM, Smith DD, Nelson RA.

Ann Surg Oncol. 2014 Oct;21(11):3448-56. doi: 10.1245/s10434-014-3930-0. Epub 2014 Jul 22.

PMID:
25047478
4.

Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.

Portschy PR, Kuntz KM, Tuttle TM.

J Natl Cancer Inst. 2014 Jul 16;106(8). pii: dju160. doi: 10.1093/jnci/dju160. Print 2014 Aug.

PMID:
25031308
5.

Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.

Jatoi I, Parsons HM.

Breast Cancer Res Treat. 2014 Nov;148(2):389-96. doi: 10.1007/s10549-014-3160-y. Epub 2014 Oct 10.

6.

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M.

Ann Surg. 2017 Mar;265(3):581-589. doi: 10.1097/SLA.0000000000001698.

PMID:
28169929
7.

Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer.

Zendejas B, Moriarty JP, O'Byrne J, Degnim AC, Farley DR, Boughey JC.

J Clin Oncol. 2011 Aug 1;29(22):2993-3000. doi: 10.1200/JCO.2011.35.6956. Epub 2011 Jun 20.

8.

Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.

Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC, Hamilton AS, Morrow M, Katz SJ.

JAMA Surg. 2017 Mar 1;152(3):274-282. doi: 10.1001/jamasurg.2016.4749.

PMID:
28002555
9.

Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.

Albert JM, Pan IW, Shih YC, Jiang J, Buchholz TA, Giordano SH, Smith BD.

Cancer. 2012 Oct 1;118(19):4642-51. doi: 10.1002/cncr.27457. Epub 2012 Aug 13.

10.

Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.

Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, Hartmann LC, Frost MH.

Ann Surg Oncol. 2010 Oct;17(10):2702-9. doi: 10.1245/s10434-010-1136-7. Epub 2010 Sep 19.

11.

Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).

Davies KR, Brewster AM, Bedrosian I, Parker PA, Crosby MA, Peterson SK, Shen Y, Volk RJ, Cantor SB.

Breast Cancer Res. 2016 Sep 20;18(1):93. doi: 10.1186/s13058-016-0752-y.

12.

Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.

Brown D, Shao S, Jatoi I, Shriver CD, Zhu K.

Cancer Epidemiol. 2016 Jun;42:24-31. doi: 10.1016/j.canep.2016.02.011. Epub 2016 Mar 18.

PMID:
26999400
13.

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.

Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES.

J Natl Cancer Inst. 2015 Sep 30;107(12):djv263. doi: 10.1093/jnci/djv263. Print 2015 Dec.

14.

Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.

Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ.

JAMA Surg. 2014 Jun;149(6):582-9. doi: 10.1001/jamasurg.2013.5689.

15.

Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.

Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y.

Cancer. 2012 Nov 15;118(22):5637-43. doi: 10.1002/cncr.27574. Epub 2012 Apr 19.

16.

Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.

Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D.

Am J Clin Oncol. 2013 Aug;36(4):375-80. doi: 10.1097/COC.0b013e318248da47.

PMID:
22643566
17.

Improved long-term survival with contralateral prophylactic mastectomy among young women.

Zeichner SB, Zeichner SB, Ruiz AL, Markward NJ, Rodriguez E.

Asian Pac J Cancer Prev. 2014;15(3):1155-62.

18.

Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.

Yao K, Winchester DJ, Czechura T, Huo D.

Breast Cancer Res Treat. 2013 Dec;142(3):465-76. doi: 10.1007/s10549-013-2745-1. Epub 2013 Nov 12. Review.

PMID:
24218052
19.

Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.

Nagar H, Yan W, Christos P, Chao KSC, Nori D, Ravi A.

Am J Clin Oncol. 2017 Jun;40(3):300-305. doi: 10.1097/COC.0000000000000144.

PMID:
25333731
20.

Surgical Management of Breast Cancer in 2010-2011 SEER Registries by Hormone and HER2 Receptor Status.

Lizarraga I, Schroeder MC, Weigel RJ, Thomas A.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S566-72. doi: 10.1245/s10434-015-4591-3. Epub 2015 May 9.

PMID:
25956579

Supplemental Content

Support Center